Nchi: Ubelgiji
Lugha: Kiingereza
Chanzo: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
Bordetella Pertussis Filamentous Hemagglutinin (FHA) 5 µg/dose; Poliovirus Type 1 (inactivated) 40 D-antigen U/1 dose; Poliovirus Type 3 (inactivated) 32 D-antigen U/1 dose; Bordetella Pertussis Pertactin 3 µg/dose; Bordetella Pertussis Toxoid (PT) 2,5 µg/dose; Bordetella Pertussis Purified Fimbrial Agglutinogens 2 and 3 (FIM) 5 µg/dose; Diphtheria Toxoid (DT) 2 ; Poliovirus Type 2 (inactivated) 8 D-antigen U/1 dose; Tetanus Toxoid 20
Sanofi Pasteur Europe S.A.
J07CA02
Diphteria Antigen, Adsorbed; Poliomyelitis Virus; Tetanus Toxoid Adsorbed; Bordetella Pertussis Antigen, Proteins
0,5 ml
Suspension for injection
Diphteria Antigen, Adsorbed; Poliomyelitis Virus; Tetanus Toxoid Adsorbed; Bordetella Pertussis Antigen, Proteins
Intramuscular use
Diphtheria-Pertussis-Poliomyelitis-Tetanus
CTI code: 241096-02 - Pack size: 10 x 0.5 ml - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 241096-01 - Pack size: 0.5 ml - Commercialisation status: YES - FMD code: 03664798033403 - CNK code: 4237939 - Delivery mode: Medical prescription; CTI code: 241096-03 - Pack size: 20 x 0.5 ml - Commercialisation status: NO - Delivery mode: Medical prescription
Commercialised: No
2002-11-25